SNSE Sensei Biotherapeutics Inc

Price (delayed)

$16.43

Market cap

$22.05M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$142.72

Enterprise value

-$129.24M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 0

Sensei Biotherapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company has developed ...

Highlights
The quick ratio has soared by 187% from the previous quarter and by 118% YoY
SNSE's debt has plunged by 68% YoY and by 31% from the previous quarter

Key stats

What are the main financial stats of SNSE

SNSE stock price

How has the Sensei Biotherapeutics stock price performed over time
Intraday
3.69%
1 week
-6.59%
1 month
-38.46%
1 year
133.38%
YTD
53.98%
QTD
-47.87%

Financial performance

How have Sensei Biotherapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$185.64M
Net income
-$184.46M
Gross margin
N/A
Net margin
N/A

Price vs fundamentals

How does SNSE's price correlate with its fundamentals

Growth

What is Sensei Biotherapeutics's growth rate over time

Valuation

What is Sensei Biotherapeutics stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A

Efficiency

How efficient is Sensei Biotherapeutics business performance

Dividends

What is SNSE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SNSE.

Financial health

How did Sensei Biotherapeutics financials performed over time
The quick ratio has soared by 187% from the previous quarter and by 118% YoY
Sensei Biotherapeutics's current ratio has soared by 184% from the previous quarter and by 111% YoY
SNSE's debt is 101% more than its equity
SNSE's debt to equity has dropped by 113% since the previous quarter and by 110% year-on-year
SNSE's debt has plunged by 68% YoY and by 31% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.